Nuno Arantes-Oliveira is the Founder and one of four partners at CR Ventures (Clinical Research Ventures). See sector focus and contact routes.
Nuno Arantes-Oliveira is the Founder and one of four partners at CR Ventures (Clinical Research Ventures), a global venture capital firm where he leverages his background as a scientist, entrepreneur, and professor to build science-based ventures. His investment thesis is highly specialized, targeting biotech and medtech companies specifically at the clinical trial stage, including those developing therapeutic drugs, diagnostic tools, or medical devices. The firm is location-agnostic and invests worldwide from offices in Singapore, Frankfurt, and Boston, focusing exclusively on the clinical phase of development. While specific check sizes and lead/follow behavior are not publicly detailed in the available sources, his role involves turning scientific knowledge into economic or social value through these clinical investments. Notable portfolio connections include his own past ventures such as Alfama, Inc., which was voted the best startup in Europe in 2005, and ATGC Portugal, a leading tech-transfer company sold in 2005. Arantes-Oliveira distinguishes himself through a distinctive point of view emphasizing consolidation and the creation of critical mass
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Lisbon when building a target list.
Investors like Nuno Arantes-Oliveira · Full investor directory · Investor access · Company funding database